Shares of retailer Bed, Bath & Beyond fell 17 percent to $61 Thursday, despite a first-quarter earnings beat.
Brian Nagel, a senior analyst at Oppenheimer, and Laura Champine of Canaccord Genuity Securities, appeared on CNBC Thursday to weigh in on the outlook for the company.